Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)718-723
Number of pages6
JournalBritish Journal of Haematology
Volume182
Issue number5
DOIs
StatePublished - Sep 2018

Keywords

  • Bruton tyrosine kinase
  • follicular lymphoma
  • ibrutinib

ASJC Scopus subject areas

  • Hematology

Cite this